Rhythm Pharmaceuticals (RYTM) Work In Process (2023 - 2025)

Rhythm Pharmaceuticals (RYTM) has 3 years of Work In Process data on file, last reported at $387000.0 in Q3 2025.

• On a quarterly basis, Work In Process fell 53.93% year-over-year to $387000.0 in Q3 2025; TTM through Sep 2025 was $387000.0, a 53.93% decrease from a year earlier, with the FY2024 full-year figure at $1.2 million, up 13.22% from the prior year.
• Work In Process for Q3 2025 stood at $387000.0, down from $767000.0 in the prior quarter.
• Over the last five years, Work In Process for RYTM reached as high as $3.5 million in Q3 2023 and fell as low as $387000.0 in Q3 2025.
• Historically, Work In Process has averaged $1.7 million across 3 years, with a median of $1.5 million in 2024.
• On a YoY basis, Work In Process climbed as much as 13.22% in 2024 and fell as far as 75.99% in 2024.
• Year by year, Work In Process stood at $1.1 million in 2023, then increased by 13.22% to $1.2 million in 2024, then plunged by 69.04% to $387000.0 in 2025.
• Per Business Quant data, the three most recent Work In Process figures were $387000.0 in Q3 2025, $767000.0 in Q2 2025, and $1.7 million in Q1 2025.